GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Veradermics, Incorporated MANE · USD

US listing · 🇺🇸 United States

Compare

143.95

+3.73%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Net income

−$70.0m

FY2023FY2025

Free cash flow

−$71.6m

FY2023FY2025

Shareholders' equity

−$121.0m

FY2023FY2025

Income statement

Fiscal years

FY2025FY2024FY2023
Research and development$62.1m$23.3m$15.0m
Operating income−$72.3m−$26.8m−$17.3m
Net income−$70.0m−$26.5m−$16.5m
Diluted earnings per share-1.87-0.13-0.08

Balance sheet

At each fiscal year end

FY2025FY2024FY2023
Total assets$152.6m$59.4m$18.5m
Cash and short-term investments$141.9m$53.1m$16.3m
Total liabilities$273.6m$4.7m$3.8m
Debt——$786,000
Shareholders' equity−$121.0m$54.7m$14.6m
Shares outstanding37m201m201m

Cash flow

Fiscal years

FY2025FY2024FY2023
Cash from operations−$71.6m−$23.7m−$13.5m
Capital spending−$24,000——
Free cash flow−$71.6m−$23.7m−$13.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Mar 2025Dec 2024
Operating income−$29.6m−$29.9m−$23.0m−$12.9m−$6.0m
Net income−$23.5m−$27.2m−$21.8m−$12.4m−$5.7m
Diluted earnings per share-0.58-0.67-0.59-0.33-0.03
Cash from operations−$14.0m−$21.0m−$23.0m−$13.0m−$3.0m
Total assets$825.7m$398.6m$152.6m—$59.4m
Cash and short-term investments$819.9m$390.8m$141.9m—$53.1m
Shareholders' equity$813.6m$391.9m−$121.0m—$54.7m

Financial ratios

Data as of 20 Oct 2026

FY2025FY2024FY2023
Return on equity57.8%-48.5%-112.8%
Return on assets-45.9%-44.6%-89.3%
Free cash flow yield-1.6%——
Earnings growth164.3%60.6%—
Current ratio16.66x11.77x5.75x
Debt to equity——0.05x
Equity ratio-79.3%92.1%79.2%
Interest coverage—-44.28x-457.06x
Buybacks as a share of market value81.5%——

Market value over time

27 Feb 2026 to 19 Oct 2026, in USD

$1.71bn$4.94bn

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.